Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.650
-0.050 (-2.94%)
At close: Aug 11, 2025, 4:00 PM
1.650
0.00 (0.00%)
After-hours: Aug 11, 2025, 4:35 PM EDT

Climb Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
Net Income
-92.98-73.9-35.12-45.24-47.48-20.67
Upgrade
Asset Writedown & Restructuring Costs
51.6651.660.18--9.16
Upgrade
Loss (Gain) From Sale of Investments
-1.36-0.76-2.33-0.180.37-
Upgrade
Stock-Based Compensation
7.115.5612.816.993.740.71
Upgrade
Other Operating Activities
0.130.180.10.8511.47-0.36
Upgrade
Change in Accounts Payable
-1.09-1.14-0.69-0.650.32-0.02
Upgrade
Change in Other Net Operating Assets
7.362.844.450.86-4.49-2.91
Upgrade
Operating Cash Flow
-29.18-15.56-20.6-37.37-36.07-14.1
Upgrade
Cash Acquisitions
-4.65-4.65---8.28
Upgrade
Sale (Purchase) of Intangibles
------0.2
Upgrade
Investment in Securities
-167.95-111.4568.9834.44-114.97-
Upgrade
Investing Cash Flow
-177.59-121.0968.9834.44-114.978.08
Upgrade
Issuance of Common Stock
130.96130.980.84-83.29-
Upgrade
Other Financing Activities
-0.25-0.25----
Upgrade
Financing Cash Flow
130.71130.730.84-177.234.93
Upgrade
Foreign Exchange Rate Adjustments
0.050.040.3-0.410.250.36
Upgrade
Net Cash Flow
-76.01-5.8849.53-3.3426.44-0.74
Upgrade
Levered Free Cash Flow
-16.14-9.543.46-20.51-25.3-6.57
Upgrade
Unlevered Free Cash Flow
-16.14-9.543.46-20.51-25.3-6.57
Upgrade
Change in Working Capital
6.271.73.760.21-4.17-2.94
Upgrade
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q